These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10053242)

  • 1. Fluctuations of international normalized ratio in patients treated with oral warfarin therapy in Sneddon's syndrome.
    Lousa M; Gobernado JM; Pardo A
    Eur J Neurol; 1999 Mar; 6(2):255. PubMed ID: 10053242
    [No Abstract]   [Full Text] [Related]  

  • 2. Warfarin in Sneddon's syndrome.
    Dupont S; Fénelon G; Saiag P; Sirmai J
    Neurology; 1996 Jun; 46(6):1781-2. PubMed ID: 8649599
    [No Abstract]   [Full Text] [Related]  

  • 3. Patient factors that influence warfarin dose response.
    White PJ
    J Pharm Pract; 2010 Jun; 23(3):194-204. PubMed ID: 21507814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Characteristics of the kidney lesion in a patient with Sneddon's syndrome].
    Kirsanova TV; Kozlovskaia NL; Kalashnikova LA; Smirnova TV; Roshchupkina SV; Khafizova EIu
    Ter Arkh; 2009; 81(8):73-7. PubMed ID: 19799206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Terbinafine and warfarin interaction].
    Schmutz JL; Barbaud A; Tréchot P
    Ann Dermatol Venereol; 1999 May; 126(5):463. PubMed ID: 10434116
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral anticoagulation for acute coronary syndromes.
    Brouwer MA; Verheugt FW
    Circulation; 2002 Mar; 105(11):1270-4. PubMed ID: 11901033
    [No Abstract]   [Full Text] [Related]  

  • 7. Toward safer warfarin therapy: does precise daily dosing improve international normalized ratio control?
    Manning DM
    Mayo Clin Proc; 2002 Aug; 77(8):873-5. PubMed ID: 12173723
    [No Abstract]   [Full Text] [Related]  

  • 8. Low-dose warfarin prophylaxis for catheter-associated thrombosis in cancer patients. Can it be safely associated with 5-Fluorouracil-based chemotherapy?
    Magagnoli M; Castagna L; Masci G; Santoro A
    Oncologist; 2004; 9(5):594-5; author reply 596. PubMed ID: 15477645
    [No Abstract]   [Full Text] [Related]  

  • 9. Sneddon's syndrome: a case report.
    Lahti J; Yu T; Burnett JW; Lutz L; LaMonte MP; Gunawardane R
    Cutis; 2001 Mar; 67(3):211-4, 220. PubMed ID: 11270293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin K in anticoagulation therapy.
    Hanslik T; Viboud C; Chadenat ML; Jubault V; Prinseau J
    Lancet; 2001 Feb; 357(9256):637; author reply 638. PubMed ID: 11558516
    [No Abstract]   [Full Text] [Related]  

  • 11. How can we improve our use of oral anticoagulants?
    Alpert JS
    Am J Med; 2006 Feb; 119(2):101-2. PubMed ID: 16443407
    [No Abstract]   [Full Text] [Related]  

  • 12. Adherence to long-term warfarin therapy remains challenging.
    Ward M
    J Manag Care Pharm; 2013 May; 19(4):290. PubMed ID: 23627574
    [No Abstract]   [Full Text] [Related]  

  • 13. The perioperative management of warfarin therapy.
    Ansell JE
    Arch Intern Med; 2003 Apr; 163(8):881-3. PubMed ID: 12719195
    [No Abstract]   [Full Text] [Related]  

  • 14. [Oral anticoagulants treatment of thrombosis].
    Matsuda T
    Nihon Naika Gakkai Zasshi; 1995 Sep; 84(9):1523-7. PubMed ID: 8537761
    [No Abstract]   [Full Text] [Related]  

  • 15. Decreased INR response secondary to warfarin-flucloxacillin interaction.
    Garg A; Mohammed M
    Ann Pharmacother; 2009 Jul; 43(7):1374-5. PubMed ID: 19584391
    [No Abstract]   [Full Text] [Related]  

  • 16. [Warfarin-bosentan interaction. Risk of big INR changes].
    Holm L; Jansson A; Noher H
    Lakartidningen; 2007 Aug 8-21; 104(32-33):2248. PubMed ID: 17822204
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevention of recurrent thrombosis in the antiphospholipid antibody syndrome: how long and how high with oral anticoagulant therapy?
    Baker RI
    Med J Aust; 2004 May; 180(9):436-7. PubMed ID: 15115417
    [No Abstract]   [Full Text] [Related]  

  • 18. Levofloxacin-warfarin interaction.
    Gheno G; Cinetto L
    Eur J Clin Pharmacol; 2001 Aug; 57(5):427. PubMed ID: 11599661
    [No Abstract]   [Full Text] [Related]  

  • 19. Warfarin for stroke prevention in atrial fibrillation: time to switch?
    Ahmad Y; Lip GY
    Int J Clin Pract; 2013 Jul; 67(7):603-5. PubMed ID: 23758442
    [No Abstract]   [Full Text] [Related]  

  • 20. Selection of Oral Anticoagulants in Ischemic Stroke Patients with Nonvalvular Atrial Fibrillation.
    Deguchi I; Tanahashi N; Takao M
    J Stroke Cerebrovasc Dis; 2018 Oct; 27(10):2627-2631. PubMed ID: 29970321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.